neurotransmitter
A M AG AZ IN E O F T H E GE OR GE WASH IN GTON IN STITU TE FOR NEUROSCI ENCE A ND
T HE G E O R G E WAS H INGTON U N IV E R SITY H OSP ITAL’ S NEUROLOGI CA L I NST I T UT E

fall 2019

T

NEUROTRANSMITTER FALL 2019

he Fall 2019 edition of Neurotransmitter focuses on the national epidemic of acute
traumatic brain injury (TBI) through the multi-faceted lens of the George Washington
University (GW).
GW Hospital’s Level 1 Trauma Center cares for these patients in the minutes and
hours after injury, often quite literally bringing them back to life. The journey to recovery takes a team of therapists, emergency room physicians, neurosurgeons, nurses,
psychiatrists, and rehabilitation specialists to restore their lives, which often are transformed by their experiences.
The most severe TBI cases are categorized as disorders of consciousness, leaving
patients with devastating symptoms. Unfortunately, clinical research for these seriously ill patients is limited, in large part due to a lack of assessment tools to measure
recovery of consciousness. To address this gap, Trudy Mallinson, PhD, from the GW
School of Medicine and Health Sciences (SMHS) Department of Clinical Research
and Leadership, has been developing a “Disorders of Consciousness Scale” to enable clinical researchers to measure their work with severe TBI patients. Chronic brain
injury is also the focus of Robert W. Turner II, PhD, also in the Department of Clinical
Research and Leadership at SMHS. He’s exploring the individual social impacts of TBI
on a special population: professional football players who suffer TBI as an inherent
consequence of the sport.
GW recently received several prestigious awards that refect the commitment our
clinical partnership has toward treating brain injury. GW Hospital was honored by the
American Heart Association/American Stroke Association with its highest award for
advancing the comprehensive care of stroke patients. Henry J. Kaminski, MD, earned
one of only 25 rare disease network grants from the National Institutes of Health (NIH)
to provide an infrastructure to study the rare autoimmune disease myasthenia gravis.
Sally Moody, PhD, the chair of the Department of Anatomy and Cell Biology at SMHS,
received an NIH grant to evaluate the genetic basis of developmental disorders.
The SMHS community recently welcomed Sanjay B. Maggirwar, PhD, as the new
chair of the Department of Microbiology, Immunology, and Tropical Medicine. His
research addresses how HIV may produce accelerated vascular aging, which would
predispose individuals to stroke at an early age.
We believe these and other stories make it evident that GW is at the forefront of the
care of traumatic brain injury, as well as many other areas of brain health. We hope you
agree and that you enjoy this edition of Neurotransmitter. Please feel free to contact
us with any questions.
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RAPID STROKE CARE
Timing is everything when it comes to stroke care, and thanks to advanced
brain imaging software, the George Washington University (GW) Hospital
can now make faster care decisions for patients experiencing a stroke.
The hospital’s new RAPID CT Perfusion software streamlines treatment decisions for doctors when patients present to the hospital with
a stroke more than six hours after the event occurred.
In the past, patients who arrived in the later stages of a stroke
would not have been candidates for aggressive stroke treatment
because it was diffcult for doctors to determine the amount of brain
damage, and whether more damage was imminent, said Kathleen
Burger, DO, director of the GW Hospital Comprehensive Stroke
Center.
Now, in only 90 seconds, the RAPID software can generate information on how much damage has occurred in the brain and what areas
have not yet been affected but are still at risk as time goes on. Burger said
that data gives doctors information to help them determine the effcacy of
certain surgical procedures.

ON THE HONOR ROLL

TOP HONOR
GW Hospital received the highest honor awarded for stroke treatment by
the American Heart Association/American Stroke Association. The award
recognizes GW Hospital’s commitment to stroke treatment.
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The George Washington University
(GW) Hospital received the American
Heart Association/American Stroke
Association’s (AHA/ASA) Get With
The Guidelines® Target: Stroke Honor
Roll Elite Plus Gold Plus Quality
Achievement Award. The award is the
highest stroke recognition possible
from the organizations. It recognizes
GW
Hospital’s
commitment
to
providing the most appropriate
stroke
treatment
according
to
nationally recognized, research-based
guidelines.
To qualify for the Target: Stroke
Elite Plus Honor Roll, GW Hospital had
to meet quality measures developed
to reduce the time between the
patient’s arrival at the hospital and
treatment with the clot-buster tissue
plasminogen activator.
According to the AHA/ASA, stroke
is the ffth-leading cause of death and
a leading cause of adult disability
in the United States. The award
program is the association’s hospitalbased quality improvement effort
that provides hospitals with tools and
resources to increase adherence to
the latest guidelines.

STUDYING GENES
LINKED TO BOS

UNDERSTANDING THE DEVELOPMENT
OF STATE DEPENDENCE AND CONTINUITY
A team from the George Washington University School of Medicine and Health Sciences (SMHS) has published a study in the Journal of Neuroscience suggesting the
thalamus, a tiny nucleus deep in the brain, controls the development of state dependence and continuity.
Previously, it was thought that to be fully functioning, the brain needed to achieve
two milestones: continuity, meaning the brain is always active; and state dependence,
meaning brain activity is modulated by sleep, waking, and attention. The circuit mechanisms behind the development of continuity and state dependence have been widely
assumed to be located in the cerebral cortex.
“Our results indicate that cellular changes in the thalamus relay function may be critical drivers for the maturation of background activity,” said Matthew Colonnese, PhD,
associate professor of pharmacology and physiology at SMHS. “Humans undergo developmental transitions in brain activity before and near birth.”
Drawing on previous work by Colonnese, his team used advanced techniques to record simultaneously from multiple brain regions to pinpoint the circuit change responsible for the acquisition of continuity and state dependence measured in the sensory
cortex. They were surprised to learn that activity changes in the thalamus, which could
explain most of these critical developmental milestones.

GW HOSPITAL EXPANDS ACCESS THROUGH HELIPAD
In Spring 2019, District of Columbia Mayor Muriel
Bowser signed a bill to allow the George Washington University (GW) Hospital to construct a helipad at its Foggy Bottom facility.
The approval followed unanimous support
from the D.C. City Council and its Committee of
the Whole. The helipad, which opened in November 2019, expands access to GW Hospital’s lifesaving critical care services, including its Level I Trauma Center care and comprehensive stroke care.
“We would like to thank everyone who assisted
us through this important pursuit, including our
patients, their loved ones, our community partners, and city and federal government representatives, as well as all of our employees
and providers,” said Kimberly Russo, MBA, MS, CEO of the GW Hospital.

Craniofacial abnormalities
are among the most prevalent birth defects, which
include branchiootorenal
spectrum disorders (BOS).
Researchers at the George
Washington University (GW)
received a $1.9 million grant
from the National Institutes
of Health to study the known
and unknown genes associated with BOS.
The research will focus
on mutations in two genes
linked to BOS, SIX1 and EYA1,
according to Sally A. Moody,
PhD, chair of the Department
of Anatomy and Cell Biology
at the GW School of Medicine and Health Sciences
(SMHS), a principal investigator on the grant.
“We hypothesize that
there are other key co-factor
proteins that bind to SIX1 to
regulate its activity, and that
mutations in these co-factors
contribute to the unknown
causes,” Moody said. “We
hope to identify these additional genes, which could
lead to more comprehensive
screening for infants with suspected hearing impairment.”
Other principal investigators include Karen Neilson,
PhD, assistant research
professor of anatomy and
cell biology at SMHS; Dominique Alfandari, PhD, of the
University of Massachusetts
Amherst; and Francesca Pignoni, PhD, of SUNY Upstate
Medical University.
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HIV-1 DEMENTIA RESEARCHER
SANJAY MAGGIRWAR JOINS SMHS
Sanjay B. Maggirwar, PhD,
MBA, who has vast experience researching underlying causes of HIV-associated
conditions, recently began
his tenure at the George
Washington University (GW)
School of Medicine and
Health Sciences as chair of
the Department of Microbiology, Immunology, and
Tropical Medicine.
His main research focus is
on the infammatory secondary complications of HIV infection experienced by those living longer with the disease, compared to their aging,
uninfected counterparts. Maggirwar is exploring the infammatory mechanisms associated with HIV-1 dementia. He also leads research projects looking at platelet-mediated
neuroinfammatory responses to HIV, accelerated vascular aging in those undergoing
combination antiretroviral therapy, and more.
Maggirwar has published nearly 100 research articles in peer-reviewed journals and
has been invited to give seminars and present at conferences and symposia around the
world. In 2017, he received the “School of Medicine and Dentistry Faculty Academic
Mentoring Award” from the University of Rochester Medical Center and, in 2016 he
received the “T32 Outstanding Program Director” award. He was also a recipient of the
“Distinguished Service Award” from the Society on Neuroimmune Pharmacology.
In addition to providing management and leadership to the department, Maggirwar
is responsible for maintaining an active, externally funded research program; overseeing the department’s research centers and collaborative research partnership; participating in and coordinating the educational programs in the department; and engaging
in service to the school and university.

SANJAY B. MAGGIRWAR,
PhD, MBA, (center) has vast experience researching underlying
causes of HIV-associated conditions. He recently began his tenure at the GW School of Medicine
and Health Sciences as chair of the
Department of Microbiology, Immunology, and Tropical Medicine.

Sanjay Maggirwar has
published nearly 100
research articles in
peer-reviewed journals
and has been invited
to give seminars and
present at conferences
and symposia
around the world.

LINKING NERVOUS SYSTEM STRESS TO FATTY LIVER DISEASE
Non-alcoholic fatty liver disease (NAFLD), the accumulation of fat in the liver of people who drink little or no alcohol, is believed to be generated and maintained
by endoplasmic reticulum (ER) stress, a protein folding process in the brain.
Researchers at the George Washington University (GW) received more than
$2.4 million from the National Institutes of Health to investigate ER stress.
NAFLD is a signifcant risk factor for Type 2 diabetes, insulin resistance,
and hepatic carcinoma, and incidence of the disease is increasing with the
obesity epidemic in the United States. The researchers, led by Colin Young,
PhD, assistant professor of pharmacology and physiology at the GW School of
Medicine and Health Sciences, aim to better understand the role of forebrain and
hypothalamic ER stress in obesity induced hepatic sympathetic overactivity and
NAFLD development.
Young and his team will examine the role of ER stress in the activation of activator
protein-1 (AP-1) — a transcription factor that regulates gene expression in response
to a variety of stimuli — in hypothalamic neurons during the development of NAFLD.
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THE LINK BETWEEN
ER AND NAFLD
Researchers at GW received
a grant from the National
Institutes of Health to
investigate endoplasmic
reticulum stress, which
is believed to cause nonalcoholic fatty liver disease.

Better Living
through Measurement

E

BY THOMAS KOHOUT

ach year, close to 3 million Traumatic
Brain Injury (TBI)-related emergencies
arrive at hospitals and ambulatory care
centers across the country, according to the Centers for Disease Control.
While many of those are relatively minor, stemming from a fall or a bump on the head,
more serious cases can result in a disruption of normal brain function, bringing on an extended period
of unconsciousness.
The more severe instances are categorized as
Disorders of Consciousness, with symptoms ranging from a lack of concentration to chronic coma to
brain death. Considering the number of people experiencing some type of serious brain injury annually, you might think there would be a wealth of clinical trials to address rehabilitation for these patients.
Unfortunately, there aren’t.
“There really hasn’t been a successful clinical trial
for severe TBI patients. They generally get stopped
early, or they don’t appear to be effective,” explains
Trudy Mallinson, PhD, OTR/L, FAOTA, FACRM, associate dean for research in health sciences and
associate professor of clinical research and leadership and of health, human function, and rehabilitation sciences at the George Washington University
School of Medicine and Health Sciences.
A key criticism of these trials, Mallinson explains,
is there aren’t good assessment tools to measure recovery of consciousness.
To address that gap, Mallinson and Theresa
Bender Pape, DrPH, clinical neuroscientist with the

Edward Hines Jr. Veterans Administration (VA) Research and Development Service and a research
associate professor at Northwestern University’s
Feinberg School of Medicine, have collaborated on
a series of studies, largely funded by the VA Health
Services Research and Development Service and
the Department of Defense, to establish and develop the Disorders of Consciousness Scale, or DOCS25: a tool enabling clinical researchers to measure
their work with severe TBI patients.
The tool uses a rating system consisting of 25
stimuli contained in four sensory domains to evaluate patients based on their responses. The four neurobehavioral domains assess specifc capabilities:
Auditory/Language, response to a voice or a command; Somatosensory, dealing with touch such as
light touch or heavy pressure, hot or cold; Visual, a
patient’s ability to focus on and track an object or
face; and Gustation/Olfactory, relating to taste or
smell, such as sweet or sour.
Responses are scored based on the patient’s best
overall observable response to a sensory stimuli. Using a psychometric approach called Rasch analysis,
these researchers have ordered the sensory items
from low to high in terms of their relative diffculty
to respond to.
“Our data show the items form a really nice hierarchy,” Mallinson says. “We are pretty convinced about
the validity of DOCS-25. We know it’s reliable.”
The next big hurdle is establishing a minimally
clinically important difference (MCID); basically fnding out how much change in the measurement matters to patients, researchers, and clinicians. While
developing DOCS-25, Mallinson and Pape realized
none of the assessment tools, including DOCS, had
a well-established MCID.
“If you have a 2-point change, does that matter?”
asks Mallinson. “How much change is enough that
researchers can say, ‘yes, that’s a real change?’ The
reason that’s important is because that’s what you
power clinical trials on. If you believe your clinical
trial is going to produce a 6-point clinical change,
plus or minus the standard deviation, that’s the information you use to power your clinical investigation.”
Mallinson says their focus now is on tying the
kinds of meaningful change that clinicians and caregivers want to see to the recovery ruler. If they can
do that, clinicians could then have the tools to show
families and caregivers where things are in terms of
recovery and help families and clinicians make better treatment decisions together.
“That’s really what drives us,” says Mallinson. “If
we can measure things better, we can understand
what we’re doing and how to treat patients better.” ■
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Tackling Traumatic
Brain Injury
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—
GW RESEARCHER ROBERT W. TURNER II,
PhD, DEVELOPS A BASELINE FOR THE
PSYCHOSOCIAL AND NEUROCOGNITIVE
FACTORS ASSOCIATED WITH
LONG-TERM EXPOSURE TO MILD
TRAUMATIC BRAIN INJURY

BY STEVE GOLDSTEIN

R

obert W. Turner II has a doctorate
in sociology from the City University of New York, but his most
signifcant degree was earned
at the School of Hard Knocks —
more familiarly known as professional football. Turner, assistant
professor of clinical research and
leadership at the George Washington University School of Medicine and Health Sciences,
is uniquely qualifed to explore mild Traumatic
Brain Injury (mTBI) and its relationship to cognitive decline and dementia.
“What I’m trying to do,” says Turner, who
was an offensive lineman in the Canadian
Football League and the NFL, “is understand
the psychosocial and neurocognitive factors
as they are associated with accelerated cognitive decline, mTBI, and potential links to
Alzheimer’s disease and related dementia.”
The NIH-funded study will collect data using
a mixed-method design that consists of a survey, focus groups, and in-depth interviews.
At some point, brain imaging may also be

SCHOOL OF HARD KNOCKS
Robert Turner’s background as an
offensive lineman makes him uniquely
qualifed to explore mild Traumatic
Brain Injury and its relationship to
cognitive decline and dementia.

employed, Turner says. His cohort will consist
of two groups of former college and NFL players, one group with members 30–49 years old,
and the other age 50 and above. Two similarly
aged groups of people who have not played
any contact sports will serve as controls.
The three research aims will enable Turner
to integrate and apply knowledge gained
through the proposed training activities by
creating a more robust portrait of psychosocial protective and risk factors that may impact
the long-term consequences of mTBI among
men than previously possible. “What we hypothesize is that those who’ve had a higher
degree of exposure to cognitive events will be
impaired,” he says, “and we should see a correlation between cognitive impairment and
white matter degradation over time.”
A major goal of the research is to reveal
both the risk factors and the protective measures attending to mTBIs. “Are there things
that these men can do that will guard against
traumatic effects or brain injury over time?”
Turner asks. “Do we see a link from injury to
cognition and is that decline different from
persons who do not sustain such an injury?”
The study is titled “An Analysis of Psychosocial Risk and Protective Factors: Accelerated Cognitive Aging and Mild Traumatic Brain
Injury (MTBI) Among Retired NFL & Former
NCAA Football Players.” The fve-year grant
from the National Institute of Aging concludes
in 2022. ■
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Turning
Heads
GW’S SYSTEMIC APPROACH TO TREATING
CONCUSSION AND TRAUMATIC BRAIN INJURY
BY STEVE GOLDSTEIN

I

n early 2018, a woman in
her 30s, we’ll call her Sue
although that’s not her real
name, decided that she’d like
to try one of those hip electric
scooters she’d seen whizzing
around town. Bad decision.
Unprepared for sharp turns
and close encounters with
cars and pedestrians, Sue lost control and crashed,
suffering a cervical vertebra injury. Rushed to the
hospital, she was checked out by the George Washington University (GW) Hospital’s Department of
Emergency Medicine (ED) staff and referred to the
Department of Neurosurgery. There she had a CT
scan to see whether there was any internal bleeding
or a skull fracture. The scan came back negative, so
attention shifted to the spinal injury. Ultimately, Sue
underwent successful surgery.
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Months later, still wearing a brace, Sue visited
the Concussion and Traumatic Brain Injury (TBI) Program Clinic at GW Hospital, complaining of headaches and dizziness. Marilyn F. Kraus, MD, director
of the clinic, determined Sue had been concussed.
“She was on pain meds, and in this case, it was hard
for her to realize she had a concussion because of
the lingering pain from the spinal injury, which may
have masked the concussion effects,” says Kraus,
who also serves as associate professor of psychiatry
and behavioral sciences in the GW School of Medicine and Health Sciences. “Almost all these c-spine
injuries have a concussion component.”
After Sue completed her rehabilitation from the
surgery and shed the brace, Kraus referred her to
the GW Hospital’s specialized physical therapy
A SEAMLESS APPROACH
unit, where Senior OutGW Hospital takes a seampatient Physical Therapist
less, multidisciplinary
Kirsten Quinn, DPT, put
approach to head injuries.
Concussion and TBI are
her on a therapy program
increasingly common
to address the vestibular
and GW has responded
(or balance) issues. Speby developing a systemic
cialized physical therapy
continuum of care for treatfor concussion and trauing insults to the brain.
matic brain injury is relatively recent and is a key
component of the continuum of care at the hospital.
Following six weeks of therapy, Sue was free of dizziness and her headaches had subsided. She decided
to stick to Capital Bikeshare and wearing helmets
when getting around town.
Good decision.
Sue’s case is illustrative of GW Hospital’s seamless, multidisciplinary approach to head injuries.
Concussion and TBI are increasingly common and
GW has responded by developing a systemic continuum of care for treating insults to the brain. Like a
point-to-point medical map, the continuum of care

When I frst started handling care for brain
injuries more than 20 years ago, it was like
having a compass and a fare gun — you did the
best you could. Now we have specialists every
step of the way and there’s a continuity at GW.
— Marilyn F. Kraus, MD
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links any necessary medical services along the route
to wellness. The map ensures each medical service
stop along the way is close enough in proximity to
allow immediate communication. Patients steadily
move on the road to recovery. Seems logical, right?
Yet the idea was decades in the making, as concussion and TBI swelled to become signifcant public
health issues.
“When I frst started handling care for brain injuries more than 20 years ago, it was like having a compass and a fare gun — you did the best you could,”
says Kraus. “Now we have specialists every step of
the way and there’s a continuity at GW.”
The challenge is massive. According to the Centers for Disease Control and Prevention, approximately 1.5 million Americans suffer a brain injury
each year, 85,000 people suffer long-term disabilities, and 50,000 people die as a result of TBI each
year. In the United States, more than 5.3 million people live with disabilities resulting from TBI. The top
three causes of TBI are: car accidents, frearms, and
falls. Young adults and the elderly are at highest risk
for TBI, and both groups are particularly susceptible
to spinal cord injuries — another type of traumatic injury that can result from those same top three causes.

DRAWING ON 20 YEARS
OF EXPERIENCE IN
TREATING BRAIN INJURIES
Marilyn F. Kraus, MD, is the
director of the Concussion and Traumatic Brain
Injury Program Clinic at
GW Hospital. She also
serves as associate
professor of psychiatry and
behavioral sciences in the
GW School of Medicine
and Health Sciences.

PHYSICAL THERAPY
FOR BRAIN INJURIES
Senior Outpatient Physical
Therapist Kirsten Quinn,
DPT, works in GW Hospital’s specialized physical
therapy unit. Specialized
physical therapy for
concussion and traumatic
brain injury is relatively
recent and is a key component of the continuum
of care at the hospital.
The list of common symptoms of a brain injury is
long, but it includes dizziness, headache, fatigue, nausea or vomiting, double or blurry vision, and diffculty
concentrating or remembering. Many people who
suffer a concussion feel better within a few days or
weeks. Others, however, may have a lengthier or more
complicated rehab, perhaps lasting months. Appropriate evaluation, management, and understanding
can help promote a faster, more complete recovery.
With heightened public awareness of concussion
and TBI, the volume of cases has risen dramatically.
According to GW’s medical records, 861 individuals
visited the concussion clinic during fscal year 2018.
Over a period of 18 months, from the beginning of
January 2017 through the end of June 2018, the GW
Hospital trauma center treated 626 patients — 328
injuries from falls, 97 from assaults, 81 from motor
vehicle accidents, 55 pedestrian mishaps, 37 from
bicycle accidents, and eight from self-harm. There
are always outliers, of course. Kraus has treated patients who have sustained head injuries from a host
of unique activities, including one from roller derby,
and another who had to be treated after repeatedly
head-butting her dog. Some people will do anything for fun.

According to the Centers for Disease Control and Prevention, approximately 1.5
million Americans suffer a brain injury each year. Each year, 85,000 people suffer
long-term disabilities, and 50,000 people die as a result of a traumatic brain injury.
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Assuming those playful head butts lead to something more serious, there are a number of things patients can expect.
When arriving in the emergency department,
the frst triage determines whether patients can be
treated as an outpatient or if they need to be admitted. One objective measure is nystagmus, sometimes known as “dancing eyes.” Out of approximately 200 patients daily, one-third have been injured (as
opposed to a medical complaint) and, of that number, an average of two patients a day have a serious
trauma, according to Robert Shesser, MD, MPH, professor and chair of the Department of Emergency
Medicine. If the concussion sustained is believed to
be mild, the patient is given basic care guidelines
and sent home.
If the head injury is more severe, on the other
hand, the patient will go to the trauma bay of the ED.
In 2013, GW Hospital frst earned a Level 1 Trauma
Center designation. There the self-described “maestro” is Babak Sarani, MD ’97, RESD ’04, the director
of Trauma and Acute Care Surgery at GW Hospital.
Sarani actually functions like an orchestra conductor
as much as a physician.
“We start with a physical exam, including assessing the patient’s level of consciousness, then we
lean very heavily on getting a CT scan,” Sarani explains. “We look at all injuries not just brain injuries.
Then we may initiate the consults to neurology and
neurosurgery. We do the coordination of the care.
Throughout the patient’s stay in the hospital, we’re
the coordinating body. We’re the ones making sure
the departments are talking to each other, that the
patient is getting adequate nutrition and so on.”
Should surgical intervention be necessary, patients are directed to GW’s Department of Neurological Surgery led by Anthony Caputy, MD, chair
of the Department of Neurological Surgery and
Hugo V. Rizzoli Professor of Neurological Surgery

SYMPTOMS OF A CONCUSSION
A traumatic brain injury (TBI) is a type of brain injury
caused by a blow to, or penetration of, the head. A TBI
can occur during a car accident, a serious fall, an explosion, or an assault, among other reasons. After a TBI,
nerve cells in the brain may be damaged. The neurons
may have trouble doing their job of carrying signals
to different parts of the brain. A concussion is a minor
form of brain injury, though some concussions can
be severe.
Typically, concussion symptoms appear soon after
an injury occurs, according to the Centers for Disease
Control and Prevention, but they can sometimes take
longer to manifest.
> Headache
> Dizziness or vertigo
> Lack of awareness
> Loss of consciousness
> Nausea and vomiting
> Poor attention and concentration
> Fatigue
> Double or blurred vision
> Irritability and/or bothered by light or noise
> Memory problems
> Sleep disturbances

A traumatic brain injury is a type of brain injury caused by a blow
to, or penetration of, the head. A TBI can occur during a car accident,
a serious fall, an explosion, or an assault among other reasons.
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TREATING TRAUMA
Robert Shesser, MD, MPH,
professor and chair of the
Department of Emergency
Medicine, (left), said two
patients a day, on average,
have a serious trauma. In
those cases, the patient
goes to the trauma bay
of the ED, where Babak
Sarani, MD ’97, RESD ’04,
is the director of Trauma
and Acute Care Surgery.
at SMHS. The department is staffed by a team of
experts trained in all aspects of the treatment and
management of neurological disorders. As a discipline, neurosurgery covers a large number of procedures from minimally invasive techniques for the
brain and spine — deep brain stimulation to treat
movement and mood disorders, craniotomy techniques for mapping brain function, radiosurgery,
carotid artery stenting, and minimally invasive
treatment of brain aneurysm (coiling) — to more traditional open surgeries to relieve cranial pressure,
treat traumatic brain injury, or correct malformations of blood vessels.
“Neurosurgery is the acute part of the continuum
of care, and, along with the trauma team, we are the
initial evaluators,” says Michael Rosner, MD, professor of neurological surgery, and a key member of
Caputy’s surgical team. Rosner brings vast experience with TBI cases. Before coming to GW, Rosner
was a staff neurosurgeon at Walter Reed, and he
also served with the 86th Combat Support Hospital
in Baghdad, Iraq, in support of Operation Iraqi Freedom. As soon as the trauma team identifes any kind
of neurological concern, “we are there within seconds,” Rosner says, adding the neurosurgeons do

their own imaging and a neurological exam, paying
particular attention to whether there is inter-cranial
bleeding.
As Caputy notes: “We get more patients because
we are a Level 1 Trauma Center. The beauty of the
system here is that there isn’t any [discussion] of who
takes the patient at the next stage of recovery.
“At GW,” he adds, “the system is among the best
in the country at ensuring patients are taken care
of appropriately by the next expert at every level
of care.”
Last in the line of GW’s continuum of care is the
Concussion/TBI Clinic, but in many ways it’s the step
that takes patients from better to back to normal.
Located in the neurology department, the clinic follows patients and organizes care soon after injury.
Patients receive treatment across the full range of
their recovery, from post-operative to the weeks,
months, or even years after the precipitating event.
Treatment can range from the subacute phase, when
the injury is just starting to heal, into the chronic
phase, typically six months after an injury and continuing throughout the patient’s life, as needed.
“We see athletes, as well as any other types of
head injury, including motor vehicle and work-

... [N]eurosurgery covers a large number of procedures from
minimally invasive techniques for the brain and spine … to more
traditional open surgeries … .
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related incidents,” says Kraus, adding that each case
requires a complete evaluation in order to develop a
comprehensive treatment plan. No two brain injuries
are alike and the consequence of two similar injuries
may be very different.
“We address all the potential abnormal conditions
relating to TBI/concussion, including headache, neck
pain, vestibular disorders, oculomotor disorders,
sleep disorders, cognitive and mood changes,” she
adds. “Symptoms may appear right away or may not
be present for days or weeks after the injury. One of
the consequences of brain injury is that the person often does not realize that a brain injury has occurred.”
When Kraus evaluates a patient who is complaining of cognitive diffculty that is interfering with daily
life, she frequently refers them to neuropsychiatrist
Antonio Puente, PhD, who performs a detailed neuropsychological exam designed to produce cognitive measures through memory, problem solving,
and attention exercises. “This will provide cognitive
measures but also tells us how the patient is doing
emotionally and helps inform treatment,” Puente explains. “More often than not, our fndings are used to
change their physical routine.”

IN NEED OF
SURGICAL INTERVENTION
Should surgical intervention be necessary as a
result of a traumatic
brain injury, patients are
directed to GW’s Department of Neurological
Surgery led by Anthony
Caputy, MD, chair of the
Department of Neurological Surgery and Hugo V.
Rizzoli Professor of Neurological Surgery at SMHS.

FIELD EXPERIENCE
Michael Rosner, MD, professor of neurological surgery,
is a key member of GW’s
neurosurgery team. Before
coming to GW, Rosner
was a staff neurosurgeon
at Walter Reed, and he
also served with the 86th
Combat Support Hospital in
Baghdad, Iraq, in support
of Operation Iraqi Freedom.
Ultimately, patients are referred for physical
therapy (PT). Senior Outpatient Physical Therapist
Kirsten Quinn is a trained therapist specializing in
concussion and TBI. Her department receives between 10 and 20 new patients each week suffering from TBI/concussion. They are scheduled for
all three therapy disciplines: speech, physical, and
occupational “to make sure we’re not missing anything,” Quinn explains. Sessions are scheduled in
the hospital but the patient is also expected to do
his/her exercises at home. Vestibular, or balance,
dysfunction is a common reason patients are referred for PT. “It’s in the patients’ best interest to
have this close-knit relationship among all our
[medical] teams,” she adds, “because we can better manage the patient and ensure all their needs
are handled.”
For patients such as Sue, GW offers an important blend of both the immediacy of treatment
and the availability of follow-up care. “The system
in place is designed to handle all comers, at all
stages, no matter the cause of the head injury,”
says Kraus. Even someone concussed by banging heads with the family pet. “I never did get a
clear answer why she was playing chicken with
her dog.” ■

GW offers an important blend of both the immediacy of treatment and
the availability of follow-up care. The system is designed to handle
all comers, at all stages, no matter the cause of the head injury.
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Turning to Biomarker to Put

TBI Symptoms in the Past

Researchers Look to Prevent
Post-Traumatic Stress Disorder
Among Patients Suffering Brain Injuries

C

BY STEVE GOLDSTEIN

ould the brain provide biological
clues following a traumatic injury
that would improve the outcome for
the patient?
The
George
Washington
University (GW) Hospital is partnering in a new study to determine
whether biomarkers in a patient who
has suffered a traumatic brain injury
(TBI) can help reduce the risk of post-TBI symptoms
such as post-traumatic stress disorder. TBIs account
for the onset of PTSD
in
approximately
REDUCING THE RISK OF PTSD
700,000
Americans
GW University Hospital is partnereach year. Depression
ing in a new study to determine
and
post-concuswhether biomarkers in a patient
sive syndrome (PCS)
who has suffered a traumatic
are also common in
brain injury can help reduce
patients who develop
the risk of post-TBI symptoms.

PTSD. Research suggests, however, that if the determinants of risk are better analyzed and understood
there is a better chance of successful preventive
interventions.
Along with Walter Reed National Military Medical
Center (Walter Reed) and the National Institutes
of Health, GW’s School of Medicine and Health
Sciences (SMHS) Department of Neurological
Surgery is collaborating in a study funded by the
Henry M. Jackson Foundation for the Advancement
of Military Medicine. Jessica Gill, PhD, of the
National Institute of Nursing Research, is serving
as principal investigator. Gill has been exploring
the mechanisms underlying neurological symptoms and defcits in military personnel with TBIs,
as well as athletes with concussions. This line of
inquiry employs a cutting-edge type of biomarker
harvesting technology using a nanoparticle capture platform in a prospective sample of patients
immediately following a trauma. Findings from her
research will identify the clinical and biological risks

Traumatic brain injuries account for the onset of PTSD
in approximately 700,000 Americans each year.
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Depression and post-concussive syndrome are common in patients who
develop PTSD. Research suggests that if the determinants of risk are better
understood there is a better chance of successful preventive interventions.

that predict PTSD onset and neurological compromise following a traumatic injury.
SMHS serves as a site for sample collection from civilian patients. Gill is joined on the
Jackson grant by Anthony Caputy, MD, chair of
the Department of Neurological Surgery and
Hugo V. Rizzoli Professor of Neurological Surgery
at SMHS, and Babak Sarani, MD ’97, RESD ’04,
director of the Center for Trauma and Critical
Care at GW Hospital and associate professor of

PTSD SIGNS AND SYMPTOMS
For some people, frightening memories of a terrible
event can come back months or even years after the
event, making daily life diffcult to handle. Mental health
experts call this post-traumatic stress disorder (PTSD).
One myth about PTSD is that it most often affects
war veterans or survivors of violent assaults, but those
who have experienced bad accidents, fres, or natural
disasters, and emergency response workers, such as
police, frefghters, and medical providers, can also experience the disorder.
People with PTSD may feel anxious or hyper-alert.
Other signs of PTSD include:
> Having frequent nightmares, fashbacks,
or other vivid memories of the event
> Being unable to recall parts of the event
> Staying away from any reminders of the event,
including people, places, thoughts, or activities
> Feeling always on guard or on edge
> Having trouble sleeping
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surgery and of emergency medicine at SMHS. The
subjects are individuals who have had a severe
closed (non-penetrating) head injury resulting from
a fall, a car accident, or an assault, to name some
examples. Researchers are collecting specimens
from these patients, specifcally blood and cerebrospinal fuid, in order to search for these biomarkers
that could predict an outcome. By examining the
proteins and lipids in the serum of the cerebrospinal
fuid they hope to determine if the level of consciousness changed.
Current scanning technologies — CT, MRI, and
other techniques — do not necessarily reveal what’s
happening at the molecular level in the brain.
According to the researchers, some small evidence
of head injury can be observed in these scans, but it’s
not that good and not very predictive of the patient’s
long-term outcome. The goal of the project is to
identify a molecular marker to correlate with clinical
examinations and imaging fndings to better predict
patient outcomes and improve their care.
Gill’s research suggests that DNA methylation
may be a putative biomarker of psychiatric risk,
as it refects long-term changes in the function
of the gene and may shape the recovery ability of
the TBI patient through changes in cell function.
Moreover, the neuroendocrine system appears to
have a determine role. Prior research has shown
that both PTSD and depression are associated with
endocrine alterations, “leading us to question if this
biological change may underlie vulnerability for
the onset of PTSD as well as depression and postconcussive syndrome following a TBI,” according to
Gill’s hypothesis. “In support of the idea of shared
vulnerability, patients with a TBI also often display
endocrine function alterations.”
Samples are still being collected at GW, from
approximately 50 individuals, ages 18 to 65, and data
continues to be tabulated and analyzed at the NIH. ■

GW Researchers Receive
$7.8 Million to Establish
Rare Disease Network for
Myasthenia Gravis

A

George Washington University (GW) research
team led by Henry Kaminski, MD, chair of the
Department of Neurology and Meta Amalia Neumann Professor of Neurology at the GW School
of Medicine and Health Sciences (SMHS), recently
received a $7.8 million award from the National Institutes of Health (NIH) to establish a rare disease
network for myasthenia gravis. The network, which
will join 24 existing NIH Rare Diseases Clinical Research Networks, will include basic and clinical investigators, patient advocacy groups, and biotechnology and pharmaceutical companies working
together to enhance therapeutic development for
this rare disease.

A $7.8 million grant from the National Institutes
of Health will fund research into the underlying
pathophysiology of myasthenia gravis. The different
subtypes of myasthenia gravis are not well understood,
and few research labs are studying the disease.

Kaminski, a renowned expert in myasthenia gravis who has devoted decades of study to the disease, is joined on the team by fellow investigators
Linda Kusner, PhD, associate research professor of
pharmacology and physiology at SMHS, and Alison
Hall, PhD, associate dean for research workforce
development at SMHS.
“Myasthenia gravis is a chronic autoimmune disease that affects how well the nerves and muscles
communicate with each other. Often patients experience extreme weakness, struggle with their
vision, and are even hospitalized because of diffculty breathing,” says Kaminski. “This grant will give
the researcher community the needed infrastructure to study this rare disease in order to develop
new therapies.”
The grant will fund research into the underlying pathophysiology of the disease. The different
subtypes of myasthenia gravis are not well understood, there are no known biomarkers, and few
research labs are studying the disease. Upward
of 30% of patients are treatment resistant, and
all suffer from undesirable or dangerous adverse
treatment side effects. The research team will focus on the differences between ocular myasthenia
and general myasthenia — subtypes that produce
different antibodies that begin attacking nerve
and muscle communication — and individualized
treatments for the 10% of myasthenia gravis patients who develop tumors triggered by the disease. Additionally, the researchers will identify
and collect biospecimens for future study and follow myasthenia gravis patients in order to identify
biomarkers.
To increase the research into myasthenia gravis,
the grant also will support a career enhancement
component featuring training and education opportunities for scientists, physicians, and the lay
public. These opportunities will not only increase
the pool of young investigators focusing their careers on rare diseases, specifcally myasthenia gravis, but improve awareness of the unique needs of
myasthenia gravis patients.
“The grant is not just a single project, but the
establishment of a resource that will drive research
for many years,” says Kaminski. “Other rare disease
networks funded in the last 10 years have advanced
treatments for these disorders that otherwise
would have been impossible.”

■
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